Cargando…

Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors

We aimed to estimate the coronavirus disease 2019 (COVID-19) vaccine acceptance rate and identify predictors associated with acceptance. To this end, we searched PubMed, Web of Science, Cochrane Library, and Embase databases until November 4, 2020. Meta-analyses were performed to estimate the rate w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiang, Yang, Liuqing, Jin, Hui, Lin, Leesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217737/
https://www.ncbi.nlm.nih.gov/pubmed/34171345
http://dx.doi.org/10.1016/j.ypmed.2021.106694
_version_ 1783710650155925504
author Wang, Qiang
Yang, Liuqing
Jin, Hui
Lin, Leesa
author_facet Wang, Qiang
Yang, Liuqing
Jin, Hui
Lin, Leesa
author_sort Wang, Qiang
collection PubMed
description We aimed to estimate the coronavirus disease 2019 (COVID-19) vaccine acceptance rate and identify predictors associated with acceptance. To this end, we searched PubMed, Web of Science, Cochrane Library, and Embase databases until November 4, 2020. Meta-analyses were performed to estimate the rate with 95% confidence intervals (CI). Predictors were identified to be associated with vaccination intention based on the health belief model framework. Thirty-eight articles, with 81,173 individuals, were included. The pooled COVID-19 vaccine acceptance rate was 73.31% (95%CI: 70.52, 76.01). Studies using representative samples reported a rate of 73.16%. The pooled acceptance rate among the general population (81.65%) was higher than that among healthcare workers (65.65%). Gender, educational level, influenza vaccination history, and trust in the government were strong predictors of COVID-19 vaccination willingness. People who received an influenza vaccination in the last year were more likely to accept COVID-19 vaccination (odds ratio: 3.165; 95%CI: 1.842, 5.464). Protecting oneself or others was the main reason for willingness, and concerns about side effects and safety were the main reasons for unwillingness. National- and individual-level interventions can be implemented to improve COVID-19 vaccine acceptance before large-scale vaccine rollout. Greater efforts could be put into addressing negative predictors associated with willingness.
format Online
Article
Text
id pubmed-8217737
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-82177372021-06-23 Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors Wang, Qiang Yang, Liuqing Jin, Hui Lin, Leesa Prev Med Article We aimed to estimate the coronavirus disease 2019 (COVID-19) vaccine acceptance rate and identify predictors associated with acceptance. To this end, we searched PubMed, Web of Science, Cochrane Library, and Embase databases until November 4, 2020. Meta-analyses were performed to estimate the rate with 95% confidence intervals (CI). Predictors were identified to be associated with vaccination intention based on the health belief model framework. Thirty-eight articles, with 81,173 individuals, were included. The pooled COVID-19 vaccine acceptance rate was 73.31% (95%CI: 70.52, 76.01). Studies using representative samples reported a rate of 73.16%. The pooled acceptance rate among the general population (81.65%) was higher than that among healthcare workers (65.65%). Gender, educational level, influenza vaccination history, and trust in the government were strong predictors of COVID-19 vaccination willingness. People who received an influenza vaccination in the last year were more likely to accept COVID-19 vaccination (odds ratio: 3.165; 95%CI: 1.842, 5.464). Protecting oneself or others was the main reason for willingness, and concerns about side effects and safety were the main reasons for unwillingness. National- and individual-level interventions can be implemented to improve COVID-19 vaccine acceptance before large-scale vaccine rollout. Greater efforts could be put into addressing negative predictors associated with willingness. Elsevier Inc. 2021-09 2021-06-22 /pmc/articles/PMC8217737/ /pubmed/34171345 http://dx.doi.org/10.1016/j.ypmed.2021.106694 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wang, Qiang
Yang, Liuqing
Jin, Hui
Lin, Leesa
Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors
title Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors
title_full Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors
title_fullStr Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors
title_full_unstemmed Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors
title_short Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors
title_sort vaccination against covid-19: a systematic review and meta-analysis of acceptability and its predictors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217737/
https://www.ncbi.nlm.nih.gov/pubmed/34171345
http://dx.doi.org/10.1016/j.ypmed.2021.106694
work_keys_str_mv AT wangqiang vaccinationagainstcovid19asystematicreviewandmetaanalysisofacceptabilityanditspredictors
AT yangliuqing vaccinationagainstcovid19asystematicreviewandmetaanalysisofacceptabilityanditspredictors
AT jinhui vaccinationagainstcovid19asystematicreviewandmetaanalysisofacceptabilityanditspredictors
AT linleesa vaccinationagainstcovid19asystematicreviewandmetaanalysisofacceptabilityanditspredictors